In Brief: ChemTrak
This article was originally published in The Gray Sheet
Executive SummaryChemTrak: Firm's point-of-care Accumeter Theophylline Test gains 510(k) clearance for use in monitoring the blood serum level of the bronchodilator/respiratory stimulant used to treat asthma. The single-use, self-contained and disposable assay is capable of "quantitative measurement of the drug in whole blood with 99% accuracy," the firm claims...
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.